Nuzenio

Yesafili

Yesafili news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 19 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Biocon announces commercial launch of Yesafili in USA - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 18:16:32 GMTBiocon Launches Eylea Interchangeable Biosimilar Yesafili in the US - Eyewire+Eyewire+ · Wed, 05 Aug 2026 18:46:03 GMTBiocon Launches Yesafili in US, Eyes H2 Growth With Existing Contracts - scanx.tradescanx.trade · Wed, 05 Aug 2026 02:59:22 GMTBiocon Launches Yesafili™ Biosimilar for Eye Diseases in the US - Machine MakerMachine Maker · Tue, 04 Aug 2026 12:14:26 GMTBiocon debuts aflibercept biosimilar in US - ET PharmaET Pharma · Tue, 04 Aug 2026 09:54:14 GMTBiocon launches interchangeable biosimilar Yesafili for retinal diseases in US market - Indian Pharma PostIndian Pharma Post · Tue, 04 Aug 2026 06:21:06 GMTYesafili, an Eylea biosimilar, launches with a price of $1,445 - Managed Healthcare ExecutiveManaged Healthcare Executive · Mon, 03 Aug 2026 18:46:35 GMTBiocon Launches Interchangeable EYLEA Biosimilar Yesafili in US - Medical DialoguesMedical Dialogues · Mon, 03 Aug 2026 13:44:26 GMT

Timeline

Fri, 07 Aug 2026 18:16:32 GMTBiocon announces commercial launch of Yesafili in USA - The Pharma Letter
Wed, 05 Aug 2026 18:46:03 GMTBiocon Launches Eylea Interchangeable Biosimilar Yesafili in the US - Eyewire+
Wed, 05 Aug 2026 02:59:22 GMTBiocon Launches Yesafili in US, Eyes H2 Growth With Existing Contracts - scanx.trade
Tue, 04 Aug 2026 12:14:26 GMTBiocon Launches Yesafili™ Biosimilar for Eye Diseases in the US - Machine Maker
Tue, 04 Aug 2026 09:54:14 GMTBiocon debuts aflibercept biosimilar in US - ET Pharma
Tue, 04 Aug 2026 06:21:06 GMTBiocon launches interchangeable biosimilar Yesafili for retinal diseases in US market - Indian Pharma Post

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yesafili.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.